Genetic testing for autism spectrum disorders

Developmental Disabilities Research Reviews

Volumn 17, Issue 1, 2011, Pages 3-8

  Bauer, Sarah C ^a   Msall, Michael E ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Asperger syndrome; Autism; Autism spectrum disorders; Chromosomal microarray; Comparative genomic hybridization; Genetic etiology; Genetic testing; Karyotype; Pervasive developmental disorder

Indexed keywords

ARTICLE; AUTISM; COMMUNITY; COMORBIDITY; DIAGNOSTIC PROCEDURE; DISABILITY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENETIC DISORDER; GENETIC SCREENING; HEALTH PRACTITIONER; HEREDITY; HUMAN; INBORN ERROR OF METABOLISM; PHENYLKETONURIA; PRIORITY JOURNAL; RETT SYNDROME; SYMPTOM; TUBEROUS SCLEROSIS;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENETIC TESTING; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84868250155     PISSN: 19405510     EISSN: 19405529     Source Type: Journal    
DOI: 10.1002/ddrr.131     Document Type: Article

References (28)

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th ed., text revised. Washington, DC: American Psychiatric Association.
2. American Psychiatric Association. 2011. Diagnostic and statistical manual of mental disorders DSM-5 development. Available at: www.dsm5.org. Accessed 10 October 2011.
3. Buxbaum JD, Cai G, Chaste P, et al. 2007. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet Part B 144B:484-491.
4. Caronna EB, Milunsky JM, Tager-Flusberg H. 2008. Autism spectrum disorders: clinical and research frontiers. Arch Dis Child 93:581-523.
5. Crino PB. 2011. mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends in Molecular Medicine 17:734-742.
6. Crocker A. 1987. Sterling D. Garrard Memorial Symposium: Community health care services for adults with mental retardation. November 18, 1986, Auburn, Massachusetts. Ment Retard 25:237-238.
7. de Vries PJ, Bolton PF. Tuberous sclerosis. In: Howlin P, Udwin O, editors. Outcomes in neurodevelopmental and genetic disorders. Cambridge, UK: Cambridge University Press. p 272-298.
8. Filipek PA, Accardo PJ, Ashwal S, et al. 2000. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 55:468-479.
9. Hagemann RJ, Hagemann PJ. 2002. Fragile X syndrome. In: Howlin P, Udwin O, editors. Outcomes in neurodevelopmental and genetic disorders.Cambridge, UK: Cambridge University Press. p 198-219.
10. Herman GE, Henninger N, Ratliff-Schaub K, et al. 2007. Genetic testing in autism: how much is enough? Genet Med 9:268-274.
11. Howlin P. 2002. Autistic disorders. In: Howlin P, Udwin O, editors. Outcomes in neurodevelopmental and genetic disorders. Cambridge, UK: Cambridge University Press. p 136-168.
12. Hyman SL, Towbin KE. 2007. Autism spectrum disorders. In: Batshaw ML, Pellegrino L, Roizen N, editors. Children with disabilities,6th ed. Baltimore, MD: Paul H. Brookes Publishing. p 325-344.
13. Levy SE, Mandell DS, Schultz RT. 2009. Autism. Lancet 374:1627-1638.
14. Lintas C, Persico AM. 2009. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet 46:1-8.
15. Manning M, Hudgins L, the Professional Practice Guidelines Committee. 2010. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 12:742-745.
16. MichelsonDJ, ShevellMI, Sherr EH, et al. 2011. Evidence report: genetic and metabolic testing on children with global developmental delay: a report of the Quality Standards Committee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 77:1629-1635.
17. Miles JH. 2011. Autism spectrum disorders. Genet Med 13:278-294.
18. Moss J, Howlin P. 2009. Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. J Intellect Disabil Res 53:852-873.
19. Muhle R, Trentacoste SV, Rapin I. 2004. The genetics of autism. Pediatrics 113:e472- e486.
20. Myers SM, Challman TD. 2011. Autism spectrum disorders. In: Voigt RG, Macias MM, Myers SM, editors. Developmental and behavioral pediatrics. USA: American Academy of Pediatrics. p 249-291.
21. Ozonoff S, Young GS, Carter A, et al. 2011. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium Study. Pediatrics 128:e488.
22. Schaefer GB, Mendelsohn NJ, the Professional Practice and Guidelines Committee. 2008. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med 10:301-305.
23. Shaffer LG. 2005. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation. Genet Med 7:650-654.
24. Shen Y, Dies KA, Holm IA, et al. 2010. Clinical genetic testing for patients with autism spectrumdisorders. Pediatrics 125:e727- e735.
25. Sherman S, Pletcher BA, Driscoll DA. 2004. Fragile X syndrome: diagnostic and carrier testing. Genet Med 7:584-587.
26. Varga EA, Pastore M, Prior T, et al. 2009. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 11:111-117.
27. Voigt RG. 2011. Developmental and behavioral diagnoses: the spectrum and continuum of developmental-behavioral disorders. In: Voigt RG, Macias MM, Myers SM, editors. Developmental and behavioral pediatrics. USA: American Academy of Pediatrics. p 121-145.
28. Young DJ, Bebbington A, Anderson A, et al. 2008. The diagnosis of autism in a female: could it be Rett syndrome? Eur J Pediatr 167:661-669.